Present and future projects of the international breast cancer study group
- 1 August 1994
- Vol. 74 (S3) , 1139-1149
- https://doi.org/10.1002/1097-0142(19940801)74:3+<1139::aid-cncr2820741524>3.0.co;2-k
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Hormonal Chemoprevention of Cancer in WomenScience, 1993
- Prognostic importance of c-erbB-2 expression in breast cancer. International (Ludwig) Breast Cancer Study Group.Journal of Clinical Oncology, 1992
- Quality of life measures for patients receiving adjuvant therapy for breast cancer: an international trialEuropean Journal Of Cancer, 1992
- Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapyThe Lancet, 1992
- Quality-of-Life-Adjusted Evaluation of Adjuvant Therapies for Operable Breast CancerAnnals of Internal Medicine, 1991
- The magnitude of endocrine effects of adjuvant chemotherapy for premenopausal breast cancer patientsAnnals of Oncology, 1990
- Prolonged Disease-Free Survival after One Course of Perioperative Adjuvant Chemotherapy for Node-Negative Breast CancerNew England Journal of Medicine, 1989
- Combination Adjuvant Chemotherapy for Node-Positive Breast CancerNew England Journal of Medicine, 1988
- Effects of Estrogens and Antiestrogens on Cell ProliferationPublished by Springer Nature ,1988
- A new endpoint for the assessment of adjuvant therapy in postmenopausal women with operable breast cancer.Journal of Clinical Oncology, 1986